Clinical Research Directory
Browse clinical research sites, groups, and studies.
HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP
Sponsor: Kocaeli University
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) procedures are commonly performed under deep sedation and are associated with a risk of hypoxemia, particularly in prone or semi-prone positions. High-flow nasal cannula (HFNC) therapy may improve oxygenation by delivering heated and humidified oxygen at high flow rates, while the Microstream Advance nasal cannula provides simultaneous nasal oxygen delivery and oral oxygen insufflation. This prospective randomized study aims to compare the effectiveness of HFNC and Microstream Advance nasal cannula in maintaining oxygenation during ERCP procedures. Patients undergoing ERCP will be randomized into two groups receiving either HFNC or Microstream Advance nasal cannula oxygen support during sedation. The primary outcomes are the incidence of desaturation and oxygen reserve index (ORi) measurements during the procedure. Secondary outcomes include time to achieve target ORi levels, respiratory complications, and procedure-related adverse events.
Key Details
Gender
All
Age Range
18 Years - 84 Years
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2026-06-29
Completion Date
2026-12-30
Last Updated
2026-05-28
Healthy Volunteers
No
Interventions
High-flow nasal canula
Heated and humidified high-flow oxygen therapy delivered through a nasal cannula during ERCP under sedation
Microstream advance nasal cannula
Oxygen support delivered through the Microstream Advance nasal cannula during ERCP under sedation.